Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease
Advances in Clinical and Experimental Medicine · 26.03.2024 · 34 (2) · 187-198
DOI: 10.17219/acem/184132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 26.03.2024. Verfasst von Agata Łukawska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Wroclaw Medical University, Poland. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Wroclaw Medical University, Poland.
Zitieren
APA
Łukawska, A., & Mulak, A. (2024). Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease. Advances in Clinical and Experimental Medicine, 34(2), 187-198. https://doi.org/10.17219/acem/184132
Vancouver
Łukawska A, Mulak A. Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease. Advances in Clinical and Experimental Medicine. 2024;34(2):187-198. doi:10.17219/acem/184132
BibTeX
@article{ukawska2024,
author = {Łukawska, Agata and Mulak, Agata},
title = {Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease},
journal = {Advances in Clinical and Experimental Medicine},
year = {2024},
volume = {34},
number = {2},
pages = {187--198},
doi = {10.17219/acem/184132}
}
EUVIMED